Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome

Schizophr Res. 2004 Feb 1;66(2-3):191-2. doi: 10.1016/S0920-9964(03)00182-8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Benzodiazepines / administration & dosage
  • Benzodiazepines / adverse effects*
  • Bipolar Disorder / complications*
  • Bipolar Disorder / drug therapy*
  • Female
  • Humans
  • Long QT Syndrome / chemically induced*
  • Middle Aged
  • Olanzapine
  • Wolff-Parkinson-White Syndrome / complications*

Substances

  • Antipsychotic Agents
  • Benzodiazepines
  • Olanzapine